TickerKhojChemicals · Chemicals: Specialty · NSE: KANORICHEM · data 2026-11-02
Kanoria Chemicals & Industries Ltd
In plain words
Price: 19.2% below its 52-week high of ₹206.
Delivery: 69.7% of traded shares were kept for delivery over the last 10 sessions, against 68.1% over the last 60.
Latest results: a net profit of ₹27 cr for the quarter ended Jun 2026.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹1,240 cr |
| Net profit (last 12 months) | ₹57 cr |
| Sales growth, 3 years (yearly) | -14.7% |
| Profit growth, 3 years (yearly) | — |
At a glance
Promoters 74.4% (unchanged in a year), pledged 29.6%, institutions 0.1%.
P/E 12.7, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 7.3%, ROCE 4.2%, operating margin 5.1%: how much profit it earns on the money it uses.
Debt/equity 0.51, Profit growth — and sales growth -14.7% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
None flagged by these rules.
- Low return on equity (7.3%).
- Promoters have pledged 29.6% of their shares.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q1 FY27)
KANORICHEM Q1 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹460.37 crore, up 1.5% YoY and up 51.2% QoQ.
Net profit was ₹27.33 crore, a turn to profit from a loss a year ago and down 13.6% QoQ.
Operating margin was 9.8% (3.6% a year ago).
EPS was ₹6.03, positive against a negative EPS a year ago and down 16.7% QoQ.
KANORICHEM के Q1 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹460.37 करोड़; पिछले साल की तुलना में 1.5% की बढ़त, पिछली तिमाही की तुलना में 51.2% की बढ़त।
शुद्ध मुनाफ़ा: ₹27.33 करोड़; एक साल पहले के घाटे से मुनाफ़े में आया, पिछली तिमाही की तुलना में 13.6% की गिरावट।
ऑपरेटिंग मार्जिन: 9.8% (एक साल पहले 3.6%)।
EPS: ₹6.03; एक साल पहले के ऋणात्मक EPS से धनात्मक हुआ, पिछली तिमाही की तुलना में 16.7% की गिरावट।
KANORICHEMના Q1 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹460.37 કરોડ; ગયા વર્ષની સરખામણીએ 1.5% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 51.2% વધારો.
ચોખ્ખો નફો: ₹27.33 કરોડ; એક વર્ષ પહેલાંની ખોટમાંથી નફામાં આવી, ગયા ક્વાર્ટરની સરખામણીએ 13.6% ઘટાડો.
ઓપરેટિંગ માર્જિન: 9.8% (એક વર્ષ પહેલાં 3.6%).
EPS: ₹6.03; એક વર્ષ પહેલાંના નકારાત્મક EPSથી હકારાત્મક થઈ, ગયા ક્વાર્ટરની સરખામણીએ 16.7% ઘટાડો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
5/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Too few delivery days to compare delivery % (0 of 10); shares delivered not comparable (0 of 12); 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results
- 11 Aug 26Results Q1 FY27 results: turned to profit vs a year ago +2.1% next session
- 25 May 26Results Q4 FY26 results: turned to profit vs a year ago +10.2% next session
- 2 Mar 26Results Q4 FY25 results: loss widened vs a year ago -4.3% next session
- 12 Feb 26Results Q3 FY26 results: turned to profit vs a year ago +3.5% next session
- 10 Nov 25Results Q2 FY26 results: turned to profit vs a year ago +2.2% next session
- 5 Aug 25Results Q1 FY26 results: loss narrowed vs a year ago -1.5% next session
- 13 Feb 25Results Q3 FY25 results: loss widened vs a year ago -8.1% next session
- 14 Nov 24Results Q2 FY25 results: loss narrowed vs a year ago -7.4% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Jun 2026 | ₹460 cr | ₹27 cr | — | 9.8% | 6.03 |
| Mar 2026 | ₹304 cr | ₹32 cr | — | 8.9% | 7.24 |
| Dec 2025 | ₹266 cr | ₹4 cr | — | 7.5% | 0.81 |
| Sept 2025 | ₹210 cr | ₹93 cr | — | 3.0% | 21.38 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 74.40% | 74.40% | 74.40% | 74.40% |
| Foreign institutions (FII) | 0.07% | 0.05% | 0.04% | 0.04% |
| Domestic institutions (DII) | 0.07% | 0.07% | 0.07% | 0.07% |
| Mutual funds | 0.07% | 0.07% | 0.07% | 0.07% |
| Retail investors | 11.80% | 12.50% | 14.02% | 14.14% |
| Number of shareholders | 14,423 | 15,700 | 16,861 | 17,295 |
Common questions
What was Kanoria Chemicals & Industries Ltd's latest quarterly profit?
Kanoria Chemicals & Industries Ltd reported a net profit of ₹27 cr for the quarter ended Jun 2026, on revenue of ₹460 cr.
How much do promoters hold in Kanoria Chemicals & Industries Ltd?
Promoters held 74.40% of Kanoria Chemicals & Industries Ltd at the end of Sept 2026, with 29.57% of promoter shares pledged.
Is Kanoria Chemicals & Industries Ltd debt-free?
Its latest reported debt-to-equity ratio is 0.51.
What is Kanoria Chemicals & Industries Ltd's P/E ratio?
About 12.7, based on the last 12 months' earnings and a price of ₹166.51 (data 2026-11-02).
What is the 52-week high and low of Kanoria Chemicals & Industries Ltd?
The 52-week high is ₹206 and the 52-week low is ₹56.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Kanoria Chemicals & Industries Ltd | ₹166.51 | ₹738 cr | 12.7 | — | 7.3% | 4.2% | 0.51 | +111.4% |
| Fairchem Organics Ltd | ₹633.15 | ₹800 cr | 33.7 | 2.8 | 2% | 3.6% | 0.32 | -16.5% |
| Amines & Plasticizers Ltd. | ₹145.5 | ₹787 cr | 20.8 | — | 13.3% | 18.3% | 0.09 | -33.8% |
| Kronox Lab Sciences Limited | ₹187.5 | ₹698 cr | 24.4 | — | 26.8% | 31.6% | 0.01 | +25.3% |
| Transpek Industry Limited | ₹1,222 | ₹690 cr | 17.5 | — | 6% | 6.2% | 0.1 | +7.6% |
| Sadhana Nitro Chem Limited | ₹2.25 | ₹682 cr | — | 1.5 | -23.5% | -13.9% | 0.25 | +23.9% |
Compare KANORICHEM with FAIRCHEMOR in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open KANORICHEM in TickerKhoj →